Search for Topics:
Title/Keyword
Journal
Submission Status
Category
 
 
Topics
Human Current and Future Model Systems
Propose a Topic

Topic Menu

► Topic Menu

Topic Editors

Institute of Neuroanatomy & Developmental Biology INDB, Eberhard Karls University Tübingen, Österbergstr. 3, 72074 Tubingen, Germany
Institute of Neuroanatomy & Developmental Biology INDB, Eberhard Karls University Tübingen, Österbergstr. 3, 72074 Tubingen, Germany
Dr. Markus Breunig
Pancreatic Development and Stem Cell Differentiation" Group, Universitätsklinikum Ulm, 89070 Ulm, Germany
share announcement

Human Current and Future Model Systems

Abstract submission deadline
closed (30 April 2023)
Manuscript submission deadline
closed (30 June 2023)
Viewed by
6145

Topic Information

Dear Colleagues,

Human models are anticipated to become more and more important not only in the field of basic but also, explicitly, translational research. Most animal models cannot mirror human development, physiology, or pathophysiology in a variety of aspects. Nevertheless, the complexity of an organism is in turn badly mimicked in conventional in vitro models. Based on the rising interest in human co-cultures and three-dimensional model systems, it becomes clear that current and future advanced in vitro human platforms will be considered crucial in the field of human research, including pharmacological and toxicological screenings.

Prof. Dr. Stefan Liebau
Dr. Kevin Achberger
Dr. Markus Breunig
Topic Editors

Keywords

  • human in vitro model
  • 3D models
  • organ-on-chip
  • 3R
  • organoids
  • assembloids
  • stem cells

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biomolecules
biomolecules 		4.8 9.4 2011 16.3 Days CHF 2700
Cells
cells 		5.1 9.9 2012 17.5 Days CHF 2700
Journal of Developmental Biology
jdb 		2.2 4.1 2013 19.6 Days CHF 1800
Journal of Molecular Pathology
jmp 		- - 2020 25.4 Days CHF 1000
Organoids
organoids 		- - 2022 15.0 days * CHF 1000

* Median value for all MDPI journals in the first half of 2024.


Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.

MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:

  1. Immediately share your ideas ahead of publication and establish your research priority;
  2. Protect your idea from being stolen with this time-stamped preprint article;
  3. Enhance the exposure and impact of your research;
  4. Receive feedback from your peers in advance;
  5. Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
16 pages, 4069 KiB  
Article
Pancreatic Cancer 3D Cell Line Organoids (CLOs) Maintain the Phenotypic Characteristics of Organoids and Accurately Reflect the Cellular Architecture and Heterogeneity In Vivo
by Sara Noorani, Shannon R. Nelson, Neil T. Conlon, Justine Meiller, Ekaterina Shcheglova, Alice Usai, Jojanneke Stoof, Letizia Palanga, Fiona O’Neill, Sandra Roche, Maura B. Cotter, Niall Swan and Naomi Walsh
Organoids 2022, 1(2), 168-183; https://doi.org/10.3390/organoids1020013 - 12 Dec 2022
Cited by 1 | Viewed by 4615
Abstract
Pancreatic cancer is a highly lethal disease. Therapeutic resistance to chemotherapy is a major cause of treatment failure and recurrence in pancreatic cancer. Organoids derived from cancer stem cells (CSC) are promising models for the advancement of personalised therapeutic responses to inform clinical [...] Read more.
Pancreatic cancer is a highly lethal disease. Therapeutic resistance to chemotherapy is a major cause of treatment failure and recurrence in pancreatic cancer. Organoids derived from cancer stem cells (CSC) are promising models for the advancement of personalised therapeutic responses to inform clinical decisions. However, scaling-up of 3D organoids for high-throughput screening is time-consuming and costly. Here, we successfully developed organoid-derived cell lines (2.5D) from 3D organoids; the cells were then expanded and recapitulated back into organoids known as cell line organoids (CLOs). The 2.5D lines were cultured long term into 2D established cell lines for downstream comparison analysis. Experimental characterisation of the models revealed that the proliferation of CLOs was slightly faster than that of parental organoids. The therapeutic response to chemotherapeutic agents in 3D CLOs and organoids showed a similar responsive profile. Compared to 3D CLOs and organoids, 2D cell lines tended to be less responsive to all the drugs tested. Stem cell marker expression was higher in either 3D CLOs or organoids compared to 2D cell lines. An in vivo tumorigenicity study found CLOs form tumours at a similar rate to organoids and retain enhanced CSC marker expression, indicating the plasticity of CSCs within the in vivo microenvironment. Full article
(This article belongs to the Topic Human Current and Future Model Systems)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop